The scientific community has clearly demonstrated that metabolic alterations induced by MetS strongly correlate with increased production of TNF-α, IL-6, and leptin, and with decreased production of adiponectin by the adipose tissue, where these molecules interfere with adipocyte metabolism [26–32]. The gene discussed is TNF; the disease is metabolic syndrome.